Home > Insider Trading > Filing (0001209191-22-016901)

Filing Details

Accession Number:: 0001209191-22-016901
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-08 08:00:11
Reporting Period:: 2022-03-04

Accepted Time:: 2022-03-08 08:00:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876378	Asensus Surgical Inc.	ASXC	Surgical & Medical Instruments & Apparatus (3841)	112962080

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585207	Bruce David Milne	C/O Asensus Surgical, Inc. 1 Tw Alexander Drive, Suite 160 Durham NC 27703		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-03-04	50,000	$0.64	294,884	No	4	P	Direct
Common Stock	Acquisiton	2022-03-04	50,000	$0.64	344,884	No	4	P	Direct
Common Stock	Acquisiton	2022-03-04	50,000	$0.63	394,884	No	4	P	Direct
Common Stock	Acquisiton	2022-03-07	50,000	$0.61	444,884	No	4	P	Direct
Common Stock	Acquisiton	2022-03-07	100,000	$0.62	544,884	No	4	P	Direct
Common Stock	Acquisiton	2022-03-07	5,768	$0.62	550,652	No	4	P	Direct
Common Stock	Acquisiton	2022-03-07	69,232	$0.63	619,884	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6305 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6385 to $0.6485 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6325 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6051 to $0.6136 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.61 to $0.6161 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6161 to $0.62 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6232 to $0.63 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
The securities held following the reported transactions include 29,231 Restricted Stock Units granted on July 1, 2021. Forfeiture restrictions will lapse on such Restricted Stock Units on the first anniversary of the date of grant, or, if earlier, on the date of the Company's 2022 annual meeting of stockholders.